Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,124 | 32,326 | 39,230 | 11,118 | 17,604 |
| TOTAL | $31,548 | $33,497 | $40,363 | $12,291 | $18,535 |
| Non-Current Assets | |||||
| PPE Net | 1,014 | 920 | 840 | 921 | 1,005 |
| Other Non-Current Assets | 9,607 | 9,961 | 10,400 | 10,775 | 11,202 |
| TOTAL | $10,621 | $10,881 | $11,240 | $11,696 | $12,207 |
| Total Assets | $42,169 | $44,378 | $51,603 | $23,987 | $30,742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,108 | 7,619 | 5,243 | 3,379 | 3,947 |
| Accrued Expenses | 3,512 | 2,214 | 3,216 | 2,926 | 3,277 |
| TOTAL | $14,559 | $10,691 | $9,411 | $7,422 | $8,638 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,008 | 4,140 | 6,264 | 8,371 | 7,484 |
| Other Non-Current Liabilities | 8,663 | 8,915 | 9,160 | 9,384 | 9,608 |
| TOTAL | $10,671 | $13,055 | $15,424 | $17,755 | $17,092 |
| Total Liabilities | $25,230 | $23,746 | $24,835 | $25,177 | $25,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,938 | 1,709 | 1,707 | 1,480 | 1,025 |
| Common Shares | 24 | 22 | 22 | 14 | 13 |
| Retained earnings | -182,737 | -173,167 | -165,263 | -157,775 | -150,989 |
| TOTAL | $16,939 | $20,632 | $26,768 | $-1,190 | $5,012 |
| Total Liabilities And Equity | $42,169 | $44,378 | $51,603 | $23,987 | $30,742 |